HALO — HALOZYME THERAPEUTICS, INC.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1159036 ·
Last close
$113.90
Market Cap
$12.93B
52W High
$116.85
52W Low
$61.23
ADV30
2,092,757
Next earnings
2026-11-02
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 480,999,000 | 401,828,000 | 287,654,000 | 229,913,000 | 2,577,408,000 | 163,138,000 | 2,433,865,000 |
| Mar 2026 | 376,708,000 | 297,470,000 | 184,517,000 | 150,049,000 | 2,672,719,000 | 309,749,000 | 2,453,083,000 |
| Dec 2025 | 451,767,000 | 372,997,000 | 240,696,000 | -141,591,000 | 2,525,323,000 | 133,820,000 | 2,476,509,000 |
| Sep 2025 | 354,264,000 | 299,022,000 | 217,921,000 | 175,225,000 | 2,221,232,000 | 419,665,000 | 1,717,317,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$818,595,000
Investing CF
$-605,719,000
Financing CF
$-110,751,000
CapEx
$-300,142,000
Dividends Paid
—
Buybacks
$-288,883,000
EPS Diluted TTM
$3.35
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$151,259,000
Inventory
$137,135,000
Receivables
$455,827,000
ST Investments
$67,865,000
EBIT TTM
$603,641,000
Pretax Income TTM
$583,338,000
Interest Exp TTM
$20,303,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,663,737,984
EBITDA
$1,050,688,000
Free Cash Flow
$337,308,640
Enterprise Value
$14,114,515,968
Total Cash
$231,003,008
Total Debt
$2,178,533,120
Shares Out
113,498,000
Trailing EPS
$3.41
Book Value
$1.26
ROE
173.7%
ROA
25.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,396,611,000 | 802,593,000 | 316,889,000 | 2,525,323,000 | 2,476,509,000 | 48,814,000 | 651,558,000 |
| Dec 2024 | 1,015,324,000 | 551,475,000 | 444,091,000 | 2,063,477,000 | 1,699,656,000 | 363,821,000 | 479,064,000 |
| Dec 2023 | 829,253,000 | 337,574,000 | 281,594,000 | 1,733,270,000 | 1,649,462,000 | 83,808,000 | 388,571,000 |
| Dec 2022 | 660,116,000 | 267,531,000 | 202,129,000 | 1,841,511,000 | 1,671,713,000 | 169,798,000 | 240,110,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$979,954,000
NetIncome TTM
$398,577,000
OpCashFlow TTM
$0
Assets (Latest)
$2,525,323,000
Forward EPS
$10.39
Max Pain — expiry 2026-12-18
max pain strike: $80.00 · spot: $113.90 · call oi: 4,305 · put oi: 1,203
Expected Move to 2026-12-18:
±$14.90
(13.08%) —
implied range
$99.00 –
$128.80
· ATM straddle on $115.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TWST | Twist Bioscience Corp | $12.12B | $182.83 | — |
| NBIX | NEUROCRINE BIOSCIENCES INC | $14.07B | $138.40 | — |
| EXEL | EXELIXIS, INC. | $14.41B | $58.16 | — |
| TECH | BIO-TECHNE Corp | $11.39B | $72.61 | — |
| RGEN | REPLIGEN CORP | $10.70B | $189.68 | — |
News headlines (Yahoo Finance, 1h cache)
Strength Seen in Halozyme Therapeutics (HALO): Can Its 3.3% Jump Turn into More Strength?
2026-09-23 09:30 · Yahoo
Halozyme (HALO) Just Made A $1.3B Bet On Itself
2026-09-22 02:57 · Yahoo
Halozyme Therapeutics (HALO) Proposes $1.05B in Convertibles. Is More Time Worth the Cost?
2026-09-21 00:27 · Yahoo
Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033
2026-09-18 03:20 · Yahoo
Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033
2026-09-16 20:30 · Yahoo
Halozyme Investor Conferences Put ENHANZE and Expanded Drug Delivery Portfolio in Focus
2026-09-02 14:40 · Yahoo
Halozyme to Participate at Upcoming Investor Conferences
2026-09-02 12:30 · Yahoo
Why Women-Run Companies Deserve a Place in Your Portfolio
2026-09-24 16:42 · Yahoo
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
2026-09-23 14:31 · Yahoo
If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now
2026-09-23 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.